Skip to main navigation Skip to search Skip to main content

Omalizumab: Anti-IgE therapy in allergy

Matthias Volkmar Kopp

Original languageEnglish
JournalCurrent Allergy and Asthma Reports
Volume2011
ISSN1529-7322
Publication statusPublished - 04.2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Cite this